# | Title | Journal | Year | Citations |
---|
1 | Genetic analysis of the human malaria parasite Plasmodium falciparum | Science | 1987 | 709 |
2 | Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite | Lancet Infectious Diseases, The | 2009 | 565 |
3 | Distribution of ADH2 and ALDH2 genotypes in different populations | Human Genetics | 1992 | 479 |
4 | The Gut Microbiota of Rural Papua New Guineans: Composition, Diversity Patterns, and Ecological Processes | Cell Reports | 2015 | 475 |
5 | A Recombinant Blood‐Stage Malaria Vaccine ReducesPlasmodium falciparumDensity and Exerts Selective Pressure on Parasite Populations in a Phase 1–2b Trial in Papua New Guinea | Journal of Infectious Diseases | 2002 | 461 |
6 | Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing | Nature | 2012 | 450 |
7 | A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010 | PLoS Neglected Tropical Diseases | 2012 | 448 |
8 | A genomic history of Aboriginal Australia | Nature | 2016 | 439 |
9 | Genome-wide and fine-resolution association analysis of malaria in West Africa | Nature Genetics | 2009 | 345 |
10 | Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples | Parasitology | 1999 | 320 |
11 | Two Nonrecombining Sympatric Forms of the Human Malaria ParasitePlasmodium ovaleOccur Globally | Journal of Infectious Diseases | 2010 | 310 |
12 | The Peopling of the Pacific from a Bacterial Perspective | Science | 2009 | 284 |
13 | Genomic insights into the peopling of the Southwest Pacific | Nature | 2016 | 262 |
14 | A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria | Nature | 2006 | 245 |
15 | Antibodies against Merozoite Surface Protein (Msp)-119 Are a Major Component of the Invasion-Inhibitory Response in Individuals Immune to Malaria | Journal of Experimental Medicine | 2001 | 244 |
16 | Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial | Lancet, The | 1999 | 243 |
17 | Plasmodium malariae and Plasmodium ovale – the ‘bashful’ malaria parasites | Trends in Parasitology | 2007 | 235 |
18 | Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness | Infection and Immunity | 2009 | 235 |
19 | Cross-Species Interactions Between Malaria Parasites in Humans | Science | 2000 | 215 |
20 | Identification and Prioritization of Merozoite Antigens as Targets of Protective Human Immunity to Plasmodium falciparum Malaria for Vaccine and Biomarker Development | Journal of Immunology | 2013 | 213 |
21 | Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax | Nature Genetics | 2016 | 194 |
22 | Strategies for Detection of Plasmodium species Gametocytes | PLoS ONE | 2013 | 185 |
23 | Association between Naturally Acquired Antibodies to Erythrocyte‐Binding Antigens ofPlasmodium falciparumand Protection from Malaria and High‐Density Parasitemia | Clinical Infectious Diseases | 2010 | 184 |
24 | Chromosome size polymorphisms in plasmodium falciparum can involve deletions and are frequent in natural parasite populations | Cell | 1986 | 178 |
25 | Measles: not just another viral exanthem | Lancet, The | 2003 | 178 |
26 | The association between mites and the increasing prevalence of asthma in village communities within the Papua New Guinea highlands | Journal of Allergy and Clinical Immunology | 1985 | 176 |
27 | Genomic analysis of local variation and recent evolution in Plasmodium vivax | Nature Genetics | 2016 | 169 |
28 | Ovalocytosis and cerebral malaria | Nature | 1995 | 168 |
29 | Emerging Viral Diseases of Southeast Asia and the Western Pacific | Emerging Infectious Diseases | 2001 | 164 |
30 | Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea | Malaria Journal | 2008 | 161 |
31 | Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis | Clinical Infectious Diseases | 2016 | 160 |
32 | Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera | Parasite Immunology | 1988 | 158 |
33 | Nitric Oxide Synthase 2Lambaréné(G‐954C), Increased Nitric Oxide Production, and Protection against Malaria | Journal of Infectious Diseases | 2001 | 152 |
34 | Dynamic molecular changes during the first week of human life follow a robust developmental trajectory | Nature Communications | 2019 | 151 |
35 | THE RISK OF MALARIAL INFECTIONS AND DISEASE IN PAPUA NEW GUINEAN CHILDREN | American Journal of Tropical Medicine and Hygiene | 2007 | 149 |
36 | The epidemiology of malaria in Papua New Guinea | Trends in Parasitology | 2003 | 148 |
37 | Virulence of Malaria Is Associated with Differential Expression ofPlasmodium falciparum varGene Subgroups in a Case‐Control Study | Journal of Infectious Diseases | 2006 | 146 |
38 | Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation | Nature Communications | 2018 | 142 |
39 | Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea | Parasitology | 1988 | 139 |
40 | Skeleton-binding protein 1 functions at the parasitophorous vacuole membrane to traffic PfEMP1 to the Plasmodium falciparum–infected erythrocyte surface | Blood | 2007 | 138 |
41 | Mass Treatment to Eliminate Filariasis in Papua New Guinea | New England Journal of Medicine | 2002 | 137 |
42 | PATHOGENESIS OF ENTERITIS NECROTICANS IN PAPUA NEW GUINEA | Lancet, The | 1976 | 133 |
43 | A Trial of a Triple-Drug Treatment for Lymphatic Filariasis | New England Journal of Medicine | 2018 | 132 |
44 | Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea | Parasitology | 2000 | 131 |
45 | Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological Agents of Pneumonia, Sepsis and Meningitis in Young Infants | | 1998 | 129 |
46 | Epidemiology of Infection in Pregnancy | Clinical Infectious Diseases | 1985 | 128 |
47 | The scent of Mycobacterium tuberculosis – Part II breath | Tuberculosis | 2009 | 128 |
48 | Plasmodium falciparum: Extensive Polymorphism in Merozoite Surface Antigen 2 Alleles in an Area with Endemic Malaria in Papua New Guinea | Experimental Parasitology | 1994 | 124 |
49 | Differential Patterns of Infection and Disease with P. falciparum and P. vivax in Young Papua New Guinean Children | PLoS ONE | 2010 | 124 |
50 | Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children | Epidemiology and Infection | 1993 | 121 |